Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 13;32(2):256-259.
doi: 10.1055/s-0042-1748534. eCollection 2022 Jun.

MRI Findings in Case of Post-COVID-19 Vaccination Rhabdomyolysis: A Rare Postvaccination Adverse Effect

Tushar M Kalekar  1 , Radhika K Jaipuria  1 , Rahul Srichand Navani  1
Affiliations
Case Reports

MRI Findings in Case of Post-COVID-19 Vaccination Rhabdomyolysis: A Rare Postvaccination Adverse Effect

Tushar M Kalekar et al. Indian J Radiol Imaging. .

Abstract

In the era of this pandemic, without any proper and efficacious availability of antiviral agents against the novel coronavirus disease 2019 (COVID-19), vaccines have come as a hope for humankind. Although adverse reactions are common after getting the COVID-19 vaccine, serious or life-threatening side effects are very uncommon in these new emergency-approved vaccines. In this case report, we describe an unusual case of adverse reaction in a patient who received the COVID-19 vaccination. The patient who received the COVID-19 vaccination presented with progressive right lower limb pain and swelling, which further progressed to bilateral shoulder pain and swelling. Ultrasonography, Doppler, and magnetic resonance imaging of right lower limb were done for the patient.

Keywords: post-COVID-19 vaccination; post-COVID-19 vaccination adverse effects; post-COVID-19 vaccination rhabdomyolysis; postvaccination rhabdomyolysis.

PubMed Disclaimer

Conflict of interest statement

Conflicting Interest None declared.

Figures

Fig. 1
Fig. 1
Gray scale ultrasonography image in longitudinal section of lower limb at the level of right calf shows extensive subcutaneous edema with hyperechoic muscle.
Fig. 2
Fig. 2
Color Doppler image at the level of proximal calf on right side showed normal color flow in popliteal vein.
Fig. 3
Fig. 3
Short tau inversion recovery coronal section shows a hyperintense signal in the lateral head of right gastrocnemius muscle, with muscle appearing mildly bulky.
Fig. 4
Fig. 4
T2 Weighted Fat Sat sagittal image showing hyperintense signal along the lateral head of right gastrocnemius muscle, as compared to surrounding muscles.
Fig. 5
Fig. 5
Post Contrast T1 weighted Fat Sat sagittal image showing heterogeneous post contrast enhancement in lateral head of right gastrocnemius muscle as compared to surrounding muscles.
Fig. 6
Fig. 6
T2 Weighted Fat Sat axial section shows the hyperintense signal in the right lateral head of the gastrocnemius. There is associated subcutaneous edema along the lateral aspect on the right side, shown by T2-weighted imaging hyperintense signal in the subcutaneous plane.
Fig. 7
Fig. 7
Diffusion-weighted/apparent diffusion coefficient images at the same level show T2 shine through.
See this image and copyright information in PMC

References

    1. WHO. WHO novel coronavirus 2019 dashboard 2019https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed January 23, 2022
    1. Katal S, Pouraryan A, Gholamrezanezhad A. COVID-19 vaccine is here: practical considerations for clinical imaging applications. Clin Imaging. 2021;76:38–41. - PMC - PubMed
    1. Press Information Bureau, Government of India. Press statement by the Drugs Controller General of India (DCGI) on restricted emergency approval of COVID-19 virus vaccine 2021https://pib.gov.in/PressReleasePage.aspx?PRID=1685761. Accessed January 23, 2022 https://www.who.int/emergencies/diseases/novel-coronavirus-2019
    1. Serum Institute of India. Side effect profile of recombinant chimpanzee adenovirus vector vaccine 2021https://www.seruminstitute.com/pdf/Recombinant_Chimpanzee_Adenovirus_vec...Accessed January 23, 2022; Or Voysey M, Clemens SAC, Madhi SA, et al; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021;397(10269):99—111. - PMC - PubMed
    1. Oxford COVID Vaccine Trial Group Ramasamy M N, Minassian A M, Ewer K Jet al.Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial Lancet 2021396(10267)1979–1993. - PMC - PubMed

Publication types